25 XP   0   0   10

Senti Biosciences Inc
Buy, Hold or Sell?

Let's analyse Senti Biosciences Inc together

PenkeI guess you are interested in Senti Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Senti Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Senti Biosciences Inc

I send you an email if I find something interesting about Senti Biosciences Inc.

Quick analysis of Senti Biosciences Inc (30 sec.)










What can you expect buying and holding a share of Senti Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.01
When do you have the money?
1 year
How often do you get paid?
45.5%

What is your share worth?

Current worth
$1.50
Expected worth in 1 year
$0.14
How sure are you?
27.3%

+ What do you gain per year?

Total Gains per Share
$-1.35
Return On Investment
-358.4%

For what price can you sell your share?

Current Price per Share
$0.38
Expected price per share
$0.35 - $0.51
How sure are you?
50%

1. Valuation of Senti Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)

$0.38

2. Growth of Senti Biosciences Inc (5 min.)




Is Senti Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$66.9m$160.4m-$70.5m-78.4%

How much money is Senti Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$17.4m-$8.8m-$8.5m-49.2%
Net Profit Margin-2,386.8%-4,636.9%--

How much money comes from the company's main activities?

3. Financial Health of Senti Biosciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#445 / 1031

Most Revenue
#537 / 1031

Most Profit
#697 / 1031

Most Efficient
#880 / 1031

What can you expect buying and holding a share of Senti Biosciences Inc? (5 min.)

Welcome investor! Senti Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Senti Biosciences Inc.

What can you expect buying and holding a share of Senti Biosciences Inc?

First you should know what it really means to hold a share of Senti Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Senti Biosciences Inc is $0.3771. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Senti Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Senti Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.50. Based on the TTM, the Book Value Change Per Share is $-0.34 per quarter. Based on the YOY, the Book Value Change Per Share is $1.34 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Senti Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.42-111.1%-0.40-105.7%-0.39-102.3%-0.36-94.2%-0.36-94.2%
Usd Book Value Change Per Share-0.36-96.4%-0.34-90.1%1.34355.3%0.1436.1%0.1436.1%
Usd Dividend Per Share0.000.0%0.000.5%0.000.0%0.000.2%0.000.2%
Usd Total Gains Per Share-0.36-96.4%-0.34-89.6%1.34355.3%0.1436.3%0.1436.3%
Usd Price Per Share0.66-0.72-3.85-4.37-4.37-
Price to Earnings Ratio-0.39--0.44--3.30--4.00--4.00-
Price-to-Total Gains Ratio-1.82--2.13--2.94-1,622.16-1,622.16-
Price to Book Ratio0.44-0.35-0.94-1,690.02-1,690.02-
Price-to-Total Gains Ratio-1.82--2.13--2.94-1,622.16-1,622.16-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.3771
Number of shares2651
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.340.14
Usd Total Gains Per Share-0.340.14
Gains per Quarter (2651 shares)-895.84362.94
Gains per Year (2651 shares)-3,583.361,451.74
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
118-3602-3593714441442
237-7203-71761528892894
355-10805-107592243334346
473-14407-143422957785798
592-18008-179253772227250
6110-21610-215084486668702
7128-25212-25091511011110154
8147-28814-28674591155511606
9165-32415-32257661299913058
10183-36017-35840741444414510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.011.00.00.0%0.011.00.00.0%0.011.00.00.0%0.011.00.00.0%
Book Value Change Per Share0.04.00.00.0%3.08.00.027.3%3.08.00.027.3%3.08.00.027.3%3.08.00.027.3%
Dividend per Share1.00.03.025.0%5.00.06.045.5%5.00.06.045.5%5.00.06.045.5%5.00.06.045.5%
Total Gains per Share0.04.00.00.0%3.08.00.027.3%3.08.00.027.3%3.08.00.027.3%3.08.00.027.3%

Fundamentals of Senti Biosciences Inc

About Senti Biosciences Inc

Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma. It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer/CRC cells. In addition, the company develops Tumor-Associated Antigen and Protective Antigen Paired Discovery Platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. The company has a strategic collaboration with Celest Therapeutics (Shanghai) Co. Ltd for the clinical development of SENTI-301A to treat solid tumors. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Fundamental data was last updated by Penke on 2024-03-28 12:49:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Senti Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Senti Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Senti Biosciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Senti Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-2,386.8%+2,386.8%
TTM-2,386.8%YOY-4,636.9%+2,250.1%
TTM-2,386.8%5Y-2,988.9%+602.1%
5Y-2,988.9%10Y-2,988.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--159.2%+159.2%
TTM-2,386.8%-202.3%-2,184.5%
YOY-4,636.9%-263.0%-4,373.9%
5Y-2,988.9%-452.4%-2,536.5%
10Y-2,988.9%-589.0%-2,399.9%
1.1.2. Return on Assets

Shows how efficient Senti Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Senti Biosciences Inc to the Biotechnology industry mean.
  • -15.7% Return on Assets means that Senti Biosciences Inc generated $-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Senti Biosciences Inc:

  • The MRQ is -15.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.7%TTM-12.7%-2.9%
TTM-12.7%YOY-4.4%-8.3%
TTM-12.7%5Y-299.8%+287.1%
5Y-299.8%10Y-299.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.7%-12.5%-3.2%
TTM-12.7%-12.2%-0.5%
YOY-4.4%-11.2%+6.8%
5Y-299.8%-13.3%-286.5%
10Y-299.8%-14.6%-285.2%
1.1.3. Return on Equity

Shows how efficient Senti Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Senti Biosciences Inc to the Biotechnology industry mean.
  • -28.0% Return on Equity means Senti Biosciences Inc generated $-0.28 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Senti Biosciences Inc:

  • The MRQ is -28.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -20.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-28.0%TTM-20.2%-7.8%
TTM-20.2%YOY-5.7%-14.5%
TTM-20.2%5Y-4,592.0%+4,571.8%
5Y-4,592.0%10Y-4,592.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-28.0%-16.0%-12.0%
TTM-20.2%-15.8%-4.4%
YOY-5.7%-13.9%+8.2%
5Y-4,592.0%-18.2%-4,573.8%
10Y-4,592.0%-19.1%-4,572.9%

1.2. Operating Efficiency of Senti Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Senti Biosciences Inc is operating .

  • Measures how much profit Senti Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Senti Biosciences Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Senti Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-866.9%+866.9%
TTM-866.9%YOY-11,528.4%+10,661.5%
TTM-866.9%5Y-4,906.6%+4,039.7%
5Y-4,906.6%10Y-4,906.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM-866.9%-208.5%-658.4%
YOY-11,528.4%-280.2%-11,248.2%
5Y-4,906.6%-459.9%-4,446.7%
10Y-4,906.6%-596.9%-4,309.7%
1.2.2. Operating Ratio

Measures how efficient Senti Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Senti Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM56.845-56.845
TTM56.845YOY117.800-60.955
TTM56.8455Y67.800-10.955
5Y67.80010Y67.8000.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.817-2.817
TTM56.8453.181+53.664
YOY117.8003.609+114.191
5Y67.8005.554+62.246
10Y67.8007.396+60.404

1.3. Liquidity of Senti Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Senti Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.62 means the company has $5.62 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Senti Biosciences Inc:

  • The MRQ is 5.619. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.444. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.619TTM6.444-0.826
TTM6.444YOY5.384+1.061
TTM6.4445Y6.337+0.108
5Y6.33710Y6.3370.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.6193.987+1.632
TTM6.4444.440+2.004
YOY5.3845.569-0.185
5Y6.3376.158+0.179
10Y6.3376.492-0.155
1.3.2. Quick Ratio

Measures if Senti Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Senti Biosciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 4.23 means the company can pay off $4.23 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Senti Biosciences Inc:

  • The MRQ is 4.232. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.860. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.232TTM6.860-2.628
TTM6.860YOY5.817+1.043
TTM6.8605Y5.943+0.917
5Y5.94310Y5.9430.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2323.653+0.579
TTM6.8604.158+2.702
YOY5.8175.515+0.302
5Y5.9436.012-0.069
10Y5.9436.206-0.263

1.4. Solvency of Senti Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Senti Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Senti Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.44 means that Senti Biosciences Inc assets are financed with 44.0% credit (debt) and the remaining percentage (100% - 44.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Senti Biosciences Inc:

  • The MRQ is 0.440. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.359. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.440TTM0.359+0.081
TTM0.359YOY0.210+0.149
TTM0.3595Y0.491-0.132
5Y0.49110Y0.4910.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4400.336+0.104
TTM0.3590.330+0.029
YOY0.2100.267-0.057
5Y0.4910.367+0.124
10Y0.4910.378+0.113
1.4.2. Debt to Equity Ratio

Measures if Senti Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Senti Biosciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 78.6% means that company has $0.79 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Senti Biosciences Inc:

  • The MRQ is 0.786. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.571. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.786TTM0.571+0.214
TTM0.571YOY0.283+0.288
TTM0.5715Y1.649-1.078
5Y1.64910Y1.6490.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7860.376+0.410
TTM0.5710.398+0.173
YOY0.2830.334-0.051
5Y1.6490.431+1.218
10Y1.6490.476+1.173

2. Market Valuation of Senti Biosciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Senti Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Senti Biosciences Inc to the Biotechnology industry mean.
  • A PE ratio of -0.39 means the investor is paying $-0.39 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Senti Biosciences Inc:

  • The EOD is -0.225. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.394. Based on the earnings, the company is expensive. -2
  • The TTM is -0.444. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.225MRQ-0.394+0.169
MRQ-0.394TTM-0.444+0.051
TTM-0.444YOY-3.301+2.856
TTM-0.4445Y-3.998+3.553
5Y-3.99810Y-3.9980.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.225-2.697+2.472
MRQ-0.394-2.422+2.028
TTM-0.444-2.709+2.265
YOY-3.301-4.116+0.815
5Y-3.998-6.257+2.259
10Y-3.998-6.478+2.480
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Senti Biosciences Inc:

  • The EOD is -0.598. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.047. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.573. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.598MRQ-1.047+0.449
MRQ-1.047TTM-0.573-0.474
TTM-0.573YOY-2.370+1.797
TTM-0.5735Y-13.496+12.923
5Y-13.49610Y-13.4960.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.598-3.344+2.746
MRQ-1.047-2.939+1.892
TTM-0.573-3.486+2.913
YOY-2.370-5.592+3.222
5Y-13.496-8.464-5.032
10Y-13.496-8.872-4.624
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Senti Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.44 means the investor is paying $0.44 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Senti Biosciences Inc:

  • The EOD is 0.252. Based on the equity, the company is cheap. +2
  • The MRQ is 0.440. Based on the equity, the company is cheap. +2
  • The TTM is 0.354. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.252MRQ0.440-0.189
MRQ0.440TTM0.354+0.086
TTM0.354YOY0.937-0.583
TTM0.3545Y1,690.018-1,689.664
5Y1,690.01810Y1,690.0180.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.2522.198-1.946
MRQ0.4402.042-1.602
TTM0.3542.121-1.767
YOY0.9372.907-1.970
5Y1,690.0183.682+1,686.336
10Y1,690.0184.114+1,685.904
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Senti Biosciences Inc.

3.1. Institutions holding Senti Biosciences Inc

Institutions are holding 25.071% of the shares of Senti Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31NEA Management Company, LLC9.93630.1947442615100
2023-12-318VC GP I LLC5.69661.7141253755825375580
2023-12-31ARK Investment Management LLC4.42220.007719698601437857.874
2023-12-31Vanguard Group Inc1.5873070705215390027.8224
2023-12-31Intel Corp1.33720.1359566500
2023-12-31Hongkou Capital LP0.69710.26131053300
2023-12-31Geode Capital Management, LLC0.5352023840600
2023-09-30Omega Fund Management LLC0.43950.074319579200
2023-12-31Bridgeway Capital Management, LLC0.32550.002114500000
2023-12-31Artal Group S A0.12470.00125555500
2023-12-31BlackRock Inc0.089904005200
2023-12-31State Street Corporation0.087803910000
2023-12-31Northern Trust Corp0.082703684800
2023-12-31Two Sigma Investments LLC0.0643028643286430
2023-12-31XTX Topco Ltd0.04860.003121645216450
2023-12-31Allen Operations LLC0.04810.00282144300
2023-12-31HARBOUR INVESTMENTS, INC.0.03370.000415000500050
2023-12-31Millennium Management LLC0.0324014415144150
2023-12-31Bank of New York Mellon Corp0.027801236900
2023-12-31Bank of America Corp0.011805241-26442-83.458
Total 25.62872.391411416328+2878504+25.2%

3.2. Funds holding Senti Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31ARK Genomic Revolution4.90380.0649218439738233821.2167
2024-02-29ARK Genomic Revolution ETF4.35760.0446194108885920.4446
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.86860.000238689900
2024-02-29Vanguard Total Stock Mkt Idx Inv0.7187032015300
2023-12-31Bridgeway Ultra-Small Company Market0.32550.051514500000
2024-01-31Fidelity Extended Market Index0.29790.000213268300
2023-06-30TD Health Sciences - I0.28740.005912803697448.2372
2024-01-31Fidelity Total Market Index0.085603812300
2023-09-30BlackRock Extended Mkt Composite0.0840.00013742400
2023-12-31BlackRock Extended Equity Market K0.07330.000232649-66-0.2017
2024-01-31Fidelity Series Total Market Index0.0709031578718429.4499
2024-01-31Fidelity Nasdaq Composite Index0.06310.00012812300
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.05060.00022255200
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.04070.000218112340.1881
2023-12-31Northern Trust Extended Eq Market Idx0.03210.00021429600
2023-12-31NT Ext Equity Mkt Idx Fd - L0.03210.00021429600
2024-01-31Spartan Total Market Index Pool E0.025501136500
2023-09-30T. Rowe Price Hlth Sci Eq Q0.02380.00210616-654-5.803
2024-02-29BMO ARK Genomic Revolution Series F0.01540.0439687300
2023-12-31Extended Equity Market Fund M0.00910.000240371924.9935
Total 12.36570.21465508300+407364+7.4%

3.3. Insider Transactions

Insiders are holding 22.401% of the shares of Senti Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2013-05-20Leslie J BrowneBUY300000.04

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Senti Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.364-0.340-7%1.340-127%0.136-367%0.136-367%
Book Value Per Share--1.4982.017-26%3.601-58%2.272-34%2.272-34%
Current Ratio--5.6196.444-13%5.384+4%6.337-11%6.337-11%
Debt To Asset Ratio--0.4400.359+23%0.210+109%0.491-10%0.491-10%
Debt To Equity Ratio--0.7860.571+37%0.283+177%1.649-52%1.649-52%
Dividend Per Share---0.002-100%0.000-100%0.001-100%0.001-100%
Eps---0.419-0.399-5%-0.386-8%-0.355-15%-0.355-15%
Free Cash Flow Per Share---0.158-0.362+129%-0.428+171%-0.341+117%-0.341+117%
Free Cash Flow To Equity Per Share---0.145-0.357+146%0.237-161%0.377-139%0.377-139%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap16797994.920-75%29474624.52032091242.130-8%171666064.500-83%194527588.593-85%194527588.593-85%
Net Profit Margin----23.8680%-46.3690%-29.8890%-29.8890%
Operating Margin----8.6690%-115.2840%-49.0660%-49.0660%
Operating Ratio---56.845-100%117.800-100%67.800-100%67.800-100%
Pb Ratio0.252-75%0.4400.354+24%0.937-53%1690.018-100%1690.018-100%
Pe Ratio-0.225+43%-0.394-0.444+13%-3.301+738%-3.998+915%-3.998+915%
Price Per Share0.377-75%0.6600.720-8%3.854-83%4.367-85%4.367-85%
Price To Free Cash Flow Ratio-0.598+43%-1.047-0.573-45%-2.370+127%-13.496+1190%-13.496+1190%
Price To Total Gains Ratio-1.037+43%-1.816-2.130+17%-2.938+62%1622.160-100%1622.160-100%
Quick Ratio--4.2326.860-38%5.817-27%5.943-29%5.943-29%
Return On Assets---0.157-0.127-19%-0.044-72%-2.998+1814%-2.998+1814%
Return On Equity---0.280-0.202-28%-0.057-80%-45.920+16317%-45.920+16317%
Total Gains Per Share---0.364-0.338-7%1.340-127%0.137-366%0.137-366%
Usd Book Value--66913000.00089901250.000-26%160421658.250-58%101212827.364-34%101212827.364-34%
Usd Book Value Change Per Share---0.364-0.340-7%1.340-127%0.136-367%0.136-367%
Usd Book Value Per Share--1.4982.017-26%3.601-58%2.272-34%2.272-34%
Usd Dividend Per Share---0.002-100%0.000-100%0.001-100%0.001-100%
Usd Eps---0.419-0.399-5%-0.386-8%-0.355-15%-0.355-15%
Usd Free Cash Flow---7041000.000-16108250.000+129%-19067500.000+171%-15211879.545+116%-15211879.545+116%
Usd Free Cash Flow Per Share---0.158-0.362+129%-0.428+171%-0.341+117%-0.341+117%
Usd Free Cash Flow To Equity Per Share---0.145-0.357+146%0.237-161%0.377-139%0.377-139%
Usd Market Cap16797994.920-75%29474624.52032091242.130-8%171666064.500-83%194527588.593-85%194527588.593-85%
Usd Price Per Share0.377-75%0.6600.720-8%3.854-83%4.367-85%4.367-85%
Usd Profit---18716000.000-17486500.000-7%-8887209.500-53%-12710167.091-32%-12710167.091-32%
Usd Revenue---557000.000-100%567750.000-100%613272.727-100%613272.727-100%
Usd Total Gains Per Share---0.364-0.338-7%1.340-127%0.137-366%0.137-366%
 EOD+3 -5MRQTTM+9 -24YOY+8 -255Y+10 -2310Y+10 -23

4.2. Fundamental Score

Let's check the fundamental score of Senti Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.225
Price to Book Ratio (EOD)Between0-10.252
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.232
Current Ratio (MRQ)Greater than15.619
Debt to Asset Ratio (MRQ)Less than10.440
Debt to Equity Ratio (MRQ)Less than10.786
Return on Equity (MRQ)Greater than0.15-0.280
Return on Assets (MRQ)Greater than0.05-0.157
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Senti Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.133
Ma 20Greater thanMa 500.405
Ma 50Greater thanMa 1000.422
Ma 100Greater thanMa 2000.440
OpenGreater thanClose0.395
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income Tax Expense  -11,97410,862-1,112-99-1,211-1,166-2,3772,40528



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets119,484
Total Liabilities52,571
Total Stockholder Equity66,913
 As reported
Total Liabilities 52,571
Total Stockholder Equity+ 66,913
Total Assets = 119,484

Assets

Total Assets119,484
Total Current Assets71,200
Long-term Assets48,284
Total Current Assets
Cash And Cash Equivalents 35,926
Net Receivables 17,704
Other Current Assets 17,570
Total Current Assets  (as reported)71,200
Total Current Assets  (calculated)71,200
+/-0
Long-term Assets
Property Plant Equipment 41,612
Long-term Assets Other 2,031
Long-term Assets  (as reported)48,284
Long-term Assets  (calculated)43,643
+/- 4,641

Liabilities & Shareholders' Equity

Total Current Liabilities12,672
Long-term Liabilities39,899
Total Stockholder Equity66,913
Total Current Liabilities
Short-term Debt 4,128
Accounts payable 1,250
Other Current Liabilities 6,305
Total Current Liabilities  (as reported)12,672
Total Current Liabilities  (calculated)11,683
+/- 989
Long-term Liabilities
Capital Lease Obligations 37,666
Long-term Liabilities Other 20
Long-term Liabilities  (as reported)39,899
Long-term Liabilities  (calculated)37,686
+/- 2,213
Total Stockholder Equity
Common Stock5
Retained Earnings -244,344
Other Stockholders Equity 311,252
Total Stockholder Equity (as reported)66,913
Total Stockholder Equity (calculated)66,913
+/-0
Other
Capital Stock5
Cash and Short Term Investments 35,926
Common Stock Shares Outstanding 44,659
Current Deferred Revenue989
Liabilities and Stockholders Equity 119,484
Net Debt 1,740
Net Invested Capital 66,913
Net Working Capital 58,528
Property Plant and Equipment Gross 47,794
Short Long Term Debt Total 37,666



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-31
> Total Assets 
0
0
374
231,661
96,702
230,916
202,362
189,441
180,792
161,425
143,630
131,766
119,484
119,484131,766143,630161,425180,792189,441202,362230,91696,702231,66137400
   > Total Current Assets 
31,709
0
1,884
1,658
60,193
827
143,919
119,761
102,579
80,511
63,492
79,007
71,200
71,20079,00763,49280,511102,579119,761143,91982760,1931,6581,884031,709
       Cash And Cash Equivalents 
0
0
1,097
985
56,034
397
139,800
114,940
57,621
31,600
36,752
39,430
35,926
35,92639,43036,75231,60057,621114,940139,80039756,0349851,09700
       Short-term Investments 
0
0
0
0
0
0
0
1,642
40,942
44,506
22,883
652
0
065222,88344,50640,9421,6420000000
       Net Receivables 
317
0
0
0
483
430
573
846
626
791
567
18,620
17,704
17,70418,620567791626846573430483000317
       Other Current Assets 
830
0
787
673
1,073
430
28
56
101
112
139
488
17,570
17,57048813911210156284301,0736737870830
   > Long-term Assets 
0
0
374
230,004
36,509
230,089
58,443
69,680
78,213
80,914
80,138
52,759
48,284
48,28452,75980,13880,91478,21369,68058,443230,08936,509230,00437400
       Property Plant Equipment 
16,139
0
0
0
33,076
44,245
54,979
66,142
74,554
76,892
76,409
43,451
41,612
41,61243,45176,40976,89274,55466,14254,97944,24533,07600016,139
       Long-term Assets Other 
0
0
374
230,004
3,433
57
3,464
243
293
471
393
1,854
2,031
2,0311,8543934712932433,464573,433230,00437400
> Total Liabilities 
0
0
350
8,179
208,159
11,101
48,096
49,098
53,529
49,085
46,214
48,830
52,571
52,57148,83046,21449,08553,52949,09848,09611,101208,1598,17935000
   > Total Current Liabilities 
4,866
0
350
129
14,543
4,051
17,798
15,837
18,053
12,866
10,426
10,114
12,672
12,67210,11410,42612,86618,05315,83717,7984,05114,54312935004,866
       Short-term Debt 
0
0
0
0
1,743
0
1,857
1,922
1,988
2,151
2,551
2,682
4,128
4,1282,6822,5512,1511,9881,9221,85701,7430000
       Accounts payable 
914
0
0
0
5,187
33
5,755
1,768
2,267
2,582
2,585
1,991
1,250
1,2501,9912,5852,5822,2671,7685,755335,187000914
       Other Current Liabilities 
435
0
350
129
5,957
4,018
9,353
12,048
12,999
7,726
5,126
4,394
6,305
6,3054,3945,1267,72612,99912,0489,3534,0185,9571293500435
   > Long-term Liabilities 
0
0
8,050
8,050
193,616
7,050
30,298
33,261
35,476
36,219
35,788
38,716
39,899
39,89938,71635,78836,21935,47633,26130,2987,050193,6168,0508,05000
       Other Liabilities 
0
0
0
0
795
545
1,280
1,088
373
0
99
0
0
009903731,0881,2805457950000
> Total Stockholder Equity
0
0
24
223,483
-111,457
219,815
154,266
140,343
127,263
112,340
97,416
82,936
66,913
66,91382,93697,416112,340127,263140,343154,266219,815-111,457223,4832400
   Common Stock
1
0
1
230,001
1
230,001
4
4
4
4
4
4
5
5444444230,0011230,001101
   Retained Earnings Total Equity00-210,705-192,008-173,286-155,076-138,436000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
1
3
-143,630
0
0
00-143,6303100000000
   Capital Surplus 
0
0
0
0
0
0
292,698
295,415
300,544
304,341
308,117
0
0
00308,117304,341300,544295,415292,698000000
   Treasury Stock0000000000000
   Other Stockholders Equity 
0
0
24
0
3,618
0
90,336
105,974
300,544
142,916
308,117
308,560
311,252
311,252308,560308,117142,916300,544105,97490,33603,61802400



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,561
Cost of Revenue-5,244
Gross Profit-2,683-2,683
 
Operating Income (+$)
Gross Profit-2,683
Operating Expense-64,082
Operating Income-66,765-66,765
 
Operating Expense (+$)
Research Development31,082
Selling General Administrative37,176
Selling And Marketing Expenses-4,176
Operating Expense64,08264,082
 
Net Interest Income (+$)
Interest Income3,566
Interest Expense-0
Other Finance Cost-0
Net Interest Income3,566
 
Pretax Income (+$)
Operating Income-66,765
Net Interest Income3,566
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-83,406-50,124
EBIT - interestExpense = -66,765
-83,406
-92,919
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-66,765-83,406
Earnings Before Interest and Taxes (EBITDA)-61,521
 
After tax Income (+$)
Income Before Tax-83,406
Tax Provision-0
Net Income From Continuing Ops-88,251-83,406
Net Income-92,919
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses69,326
Total Other Income/Expenses Net-16,641-3,566
 

Technical Analysis of Senti Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Senti Biosciences Inc. The general trend of Senti Biosciences Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Senti Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Senti Biosciences Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.5 < 0.5 < 0.51.

The bearish price targets are: 0.3635 > 0.3549 > 0.35.

Tweet this
Senti Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Senti Biosciences Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Senti Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Senti Biosciences Inc. The current macd is -0.00597222.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Senti Biosciences Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Senti Biosciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Senti Biosciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Senti Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartSenti Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Senti Biosciences Inc. The current adx is 14.14.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Senti Biosciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Senti Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Senti Biosciences Inc. The current sar is 0.50702.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Senti Biosciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Senti Biosciences Inc. The current rsi is 42.13. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Senti Biosciences Inc Daily Relative Strength Index (RSI) ChartSenti Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Senti Biosciences Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Senti Biosciences Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Senti Biosciences Inc Daily Stochastic Oscillator ChartSenti Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Senti Biosciences Inc. The current cci is -101.67110681.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Senti Biosciences Inc Daily Commodity Channel Index (CCI) ChartSenti Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Senti Biosciences Inc. The current cmo is -21.57309195.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Senti Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartSenti Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Senti Biosciences Inc. The current willr is -88.6.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Senti Biosciences Inc Daily Williams %R ChartSenti Biosciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Senti Biosciences Inc.

Senti Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Senti Biosciences Inc. The current atr is 0.05130478.

Senti Biosciences Inc Daily Average True Range (ATR) ChartSenti Biosciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Senti Biosciences Inc. The current obv is 386,677,776.

Senti Biosciences Inc Daily On-Balance Volume (OBV) ChartSenti Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Senti Biosciences Inc. The current mfi is 45.42.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Senti Biosciences Inc Daily Money Flow Index (MFI) ChartSenti Biosciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Senti Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-16STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-21BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Senti Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Senti Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.133
Ma 20Greater thanMa 500.405
Ma 50Greater thanMa 1000.422
Ma 100Greater thanMa 2000.440
OpenGreater thanClose0.395
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Senti Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Senti Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Senti Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Senti Biosciences Inc

I send you an email if I find something interesting about Senti Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Senti Biosciences Inc.

Receive notifications about Senti Biosciences Inc in your mailbox!